Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | zye | Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-4-(2-oxo-1- pyrrolidinyl)-1H-indole-6-carboxamide | 2wez | 85.31 | | 23. |
2 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | zy4 | Human BACE-1 in complex with 6-ethyl-1-methyl-N-((1S)-2-oxo-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl)-1,3,4,6- tetrahydro(1,2)thiazepino(5,4,3-cd)indole-8-carboxamide 2,2-dioxide | 2wf4 | 87.57 | | 13. |
3 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | zy3 | Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-1, 3,4,5-tetrahydro-2,1-benzothiazepine-8-carboxamide 2,2-dioxide | 2wf3 | 86.58 | | 19. |
4 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | zy2 | Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4,7, 8-tetrahydro-1H,6H-(1,2,5)thiadiazepino(5,4,3-de)quinoxaline-10- carboxamide 2,2-dioxide | 2wf2 | 84.47 | | 26. |
5 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | zy1 | Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl(methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4- dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9-carboxamide 2,2- dioxide | 2wf1 | 85.08 | | 2. |
6 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | zpx | Crystal structure of BACE1 with its inhibitor | 3uqu | 87.18 | | no data |
7 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | xfi | Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-((methylsulfonyl)(phenyl)amino)benzamide | 2xfi | 83.06 | | 15. |
8 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vg6 | Human BACE-1 in complex with 3-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-5-(2-oxo-1-pyrrolidinyl)benzamide | 2vj7 | 87.76 | | 40. |
9 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vg5 | Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide | 2vj6 | 89.05 | | 13. |
10 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vg5 | Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide | 2xfj | 88.8 | | 13. |
11 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vg4 | Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(2-oxo- 1-pyrrolidinyl)-5-(propyloxy)benzamide | 2viz | 89.01 | | 605. |
12 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vg3 | Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(pentylsulfonyl)benzamide | 2viy | 83.43 | | 1800. |
13 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vg0 | Human BACE-1 in complex with N-((1S,2R)-1-benzyl-2-hydroxy-3-((1,1,5- trimethylhexyl)amino)propyl)-3-(ethylamino)-5-(2-oxopyrrolidin-1-yl) benzamide | 2vie | 89.07 | | 33. |
14 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | sii | Crystal Structure of Human Beta Secretase Complexed with Spiropiperdine Iminohydantoin Inhibitor | 3fkt | 80.87 | | 2800. |
15 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | sc7 | Structure of BACE Bound to SCH734723 | 2qp8 | 79.23 | | 8. |
16 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | sc6 | Structure of BACE Bound to SCH745966 | 2qmg | 87.34 | | 0.7 |
17 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | rvi | Structure of Bace-1 (Beta-Secretase) in Complex with 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(cyclohexylmethyl)pentanamide | 3rvi | 86.73 | | 11. |
18 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | rtn | Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Amino-6-o-tolylquinolin-3-yl)-N-cyclohexylpropanamide | 3rtn | 86.37 | | 74. |
19 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | qud | human Bace (beta secretase) in complex with Cyclohexanecarboxylic acid (2-(2-am ino-6-phenoxy-4H-quinazolin-3-yl)-2 -cyclohexyl-ethyl)- amide | 2wjo | 86.05 | | no data |
20 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | qin | Crystal Structure of Human Beta Secretase Complexed with inhibitor | 2oah | 86.82 | | 11. |
21 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | qbh | Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors | 3qbh | 88.63 | | 150. |
22 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | pb8 | Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3R)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-N-((1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-2-(1,2,3,4-tetrahydro-3-isoquinolinyl)ethyl)-4-phenylbutanamide | 3skg | 76.54 | | 8. |
23 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | pb7 | Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3S)-3-(acetylamino)-3-(butan-2-yl)-2-oxopyrrolidin-1-yl)-N-((2S,3R)-3-hydroxy-4-((3-methoxybenzyl)amino)-1-phenylbutan-2-yl)-4-phenylbutanamide | 3skf | 79.74 | | 5. |
24 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | pb0 | Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with BMS-693391 AKA (2S)-2-((3R)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-N-((1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-2-((2R,4R)-4-propoxy-2-pyrrolidinyl)ethyl)-4-phenylbutanamide | 3r2f | 78.42 | | 1.4 |
25 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | p6j | co-crystal structure of BACE with inhibitor AM-6494 | 6pz4 | 81.05 | | no data |
26 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | mr0 | Potent and selective isophthalamide S2 hydroxyethylamine inhibitor of BACE1 | 2p83 | 83.36 | | 11. |
27 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | m7d | Structure of BACE-1 in complex with Ligand 13 | 6od6 | 77.73 | | no data |
28 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | l3j | BACE1 in complex with a macrocyclic inhibitor | 6nv7 | 85.61 | | no data |
29 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | l01 | BACE (Beta Secretase) in complex with a nanomolar non-peptidic inhibitor | 1w51 | 88.2 | | 500. |
30 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | l00 | Crystal structure of Human Bace-1 bound to inhibitor | 2ntr | 82.92 | | no data |
31 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | i6x | Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COMPOUND (R)-41) | 4b00 | 83.43 | | 2.44 |
32 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | i03 | Crystal structure of human Beta-secretase complexed with inhibitor | 2is0 | 89.36 | | 200. |
33 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | i02 | Crystal structure of human Beta-secretase complexed with inhibitor | 2irz | 89.09 | | 12. |
34 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | hrv | Structure of Bace-1 in complex with Ligand 8 | 6e3z | 79.83 | | no data |
35 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | frp | Crystal structure of beta-secretase complexed with an amino-ethylene inhibitor | 2fdp | 87.43 | | 26. |
36 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | f1n | Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)-piperidin-4-yl]-2-(2-methyl-4-sulfamoyl-phenoxy)-acetamide | 2zjn | 78.11 | | no data |
37 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | f1m | Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)-piperidin-4-yl]-2-(4-sulfamoyl-phenoxy)-acetamide | 2zjm | 85.64 | | no data |
38 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | dwd | Crystal structure of BACE1 in complex with aminooxazoline xanthene 11a | 4frk | 80.72 | | 8. |
39 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | cs9 | Structure of BACE Bound to SCH735310 | 2qmf | 84.32 | | 3. |
40 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | cs5 | Structure of BACE1 bound to SCH626485 | 2qk5 | 82.48 | | 8. |
41 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | cs5 | Structure of BACE Bound to SCH589432 | 3l58 | 82.04 | | 8. |
42 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c83 | Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide | 6jt3 | 83.52 | | no data |
43 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c7x | Crystal Structure of BACE1 in complex with N-(3-((4S,5S)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide | 6jsf | 90.09 | | no data |
44 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c7o | Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide | 6jsn | 74.4 | | no data |
45 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c6u | Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-chloropyridine-2-carboxamide | 6jsg | 83.89 | | no data |
46 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c6r | Crystal Structure of BACE1 in complex with N-(3-((4S,5R)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide | 6jse | 91.45 | | no data |
47 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c6a | Design and synthesis of hydroxyethylamine (hea) BACE-1 inhibitors: prime side chromane-containing inhibitors | 3qi1 | 86.56 | | 22. |
48 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bxq | Crystal Structure of Human Beta Secretase in Complex with NVP-BXQ490 | 4d88 | 86.52 | | 49. |
49 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bxd | Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a co-crystallization experiment | 4d8c | 81.52 | | 2. |
50 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bxd | Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a soaking experiment | 4d89 | 82.64 | | 2. |
51 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | buh | Crystal Structure of Human BACE-1 in Complex with CNP520 | 6eqm | 78.65 | | no data |
52 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bjc | Human bace-1 complex with bjc060 | 3k5g | 84.98 | | 2.5 |
53 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bdw | Structure of BACE Bound to SCH736062 | 3l5e | 77.87 | | 27. |
54 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | ayh | Human BACE-1 COMPLEX WITH AYH011 | 3k5f | 87.71 | | 3700. |
55 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | aa9 | Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-((methylsulfonyl)(phenyl)amino)benzamide | 2xfk | 84.41 | | 3. |
56 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 957 | SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors | 4i0i | 83.17 | | no data |
57 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 957 | BACE-1 in complex with ELN475957 | 3nsh | 83.17 | | 470. |
58 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 916 | Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors | 4exg | 86.72 | | 8.5 |
59 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 879 | Bace1 in complex with the aminopyridine Compound 44 | 3l38 | 78.72 | | 100. |
60 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 74a | Structure of BACE bound to SCH743813 | 3lnk | 71.47 | | 1150. |
61 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 712 | Crystal Structure of Human Beta Secretase Complexed with inhibitor | 2ph6 | 89.26 | | 27. |
62 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 6bs | Crystal structure of BACE1 in complex with 3-(2-amino-6-(o-tolyl)quinolin-3-yl)-N-(3,3-dimethylbutyl)propanamide | 5ie1 | 81.4 | | 140. |
63 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 68m | Crystal structure of BACE1 in complex with aminoquinoline compound 1 | 5i3v | 86.71 | | 16. |
64 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 68j | Crystal structure of BACE1 in complex with aminoquinoline inhibitor 6 | 5i3x | 85.18 | | 8. |
65 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 625 | Bace-1 with the aminopyridine Compound 32 | 3l3a | 81.22 | | 420. |
66 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 5ha | Crystal structure of BACE1 complexed with an inhibitor | 3tpr | 76.96 | | 19.9 |
67 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 5ha | Crystal structure of BACE1 complexed with an inhibitor | 3tpp | 91.82 | | 15. |
68 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 5ha | Crystal structure of human beta secretase complexed with inhibitor | 2b8l | 90.01 | | 15. |
69 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 508 | Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through Conformational Design for Maintenance of Ligand Binding Efficiency | 3ufl | 88.61 | | 150. |
70 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 4qf | BACE1 in complex with 8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-7-methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one | 4zpg | 86.28 | | 55. |
71 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 4qd | BACE1 in complex with 8-(3-((1-aminopropan-2-yl)oxy)benzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one | 4zpf | 83.26 | | 180. |
72 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 4qa | BACE1 in complex with 4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one | 4zpe | 86.42 | | 450. |
73 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 411 | X-ray structure of Bace-1 in complex with compound 6g | 2ze1 | 78.09 | | 600. |
74 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3ut | Crystal structure of BACE1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22 | 4wtu | 83.58 | | 0.3 |
75 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3rs | Structure of Bace-1 (Beta-Secretase) in complex with (R)-3-(2-amino-6-o-tolylquinolin-3-yl)-N-((R)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-methylpropanamide | 3rsv | 86.97 | | 0.7 |
76 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3mr | Structure of BACE complexed to compound 3a | 2q15 | 81.97 | | 11. |
77 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3lo | Crystal structure of BACE1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49 | 4rcf | 83.85 | | 4. |
78 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3ln | Crystal structure of BACE1 in complex with aminooxazoline xanthene inhibitor 2 | 4rce | 81.62 | | 2. |
79 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3kw | BACE-1 in complex with 2-(((1R,3S)-3-(((R)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidin-4-yl)methyl)cyclohexyl)amino)quinolin-1-ium | 4r95 | 73.35 | | 14. |
80 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3hf | Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with bms-655295 aka n~3~-((1s,2r)-1- benzyl-2-hydroxy-3-((3-methoxybenzyl)amino)propyl)-n~1~, n~1~-dibutyl-1h-indole-1,3-dicarboxamide | 3ohf | 80.77 | | 94. |
81 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3bn | Crystal structure of human Beta-secretase complexed with L-L000430,469 | 2b8v | 87.16 | | 98. |
82 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 32p | Crystal structure of human Beta secretase complexed with inhibitor | 1tqf | 83.45 | | 1400. |
83 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 318 | Structure of BACE Bound to SCH726222 | 3cid | 84.28 | | 5. |
84 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 316 | Structure of BACE Bound to SCH709583 | 3cic | 83.73 | | 3. |
85 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 2li | Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents | 3ivi | 92.87 | | 12. |
86 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1yu | Crystal Structure of Human Beta Secretase in Complex with compound 12a | 4lxm | 82.07 | | 88. |
87 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1yt | Crystal Structure of Human Beta Secretase in Complex with compound 11d | 4lxk | 82.87 | | 4. |
88 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1ys | Crystal Structure of Human Beta Secretase in Complex with Compound 11a | 4lxa | 84.15 | | 2. |
89 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1r8 | Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 13 | 4ke0 | 87.4 | | 17. |
90 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1r6 | Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 19 | 4ke1 | 85.67 | | 2.5 |
91 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1qu | Bace-1 inhibitor complex | 4k9h | 86.85 | | 76. |
92 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1qt | Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivity, and cell activity | 4k8s | 87.03 | | 36. |
93 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1li | Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relationship of P1 Substituents | 3ivh | 84.71 | | 47. |
94 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1bl | SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors. | 4i0h | 82.08 | | no data |
95 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1be | Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors | 4i1c | 85.9 | | 8. |
96 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1bc | Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors | 4i12 | 79.45 | | 406. |
97 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1b8 | Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | 4i0e | 78.57 | | no data |
98 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1b7 | Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | 4i0d | 86.44 | | 610. |
99 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0xa | BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571 | 4gmi | 89.95 | | no data |
100 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0n1 | BACE-1 in complex with HEA-macrocyclic inhibitor, MV078512 | 4dpi | 89.28 | | 78. |
101 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0kn | Structure of Bace-1 (Beta-Secretase) in Complex with (2R)-N-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3-hydroxy-4-((S)-6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridine]-4'-ylamino)butan-2-yl)-2-methoxypropanamide | 4dh6 | 86.48 | | 16.8 |
102 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0k9 | Crystal structure of BACE1 in complex with hydroxyethylamine inhibitor 37 | 4di2 | 84.45 | | 5.5 |
103 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0gu | Crystal Structure of Human Beta Secretase in Complex with NVP-BVI151 | 4d85 | 89.86 | | 140. |
104 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0gt | Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a soaking experiment | 3vg1 | 86.74 | | 55. |
105 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0gt | Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a co-crystallization experiment | 4d83 | 87.38 | | 55. |
106 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0gs | Crystal Structure of Human Beta Secretase in Complex with NVP-BQQ711 | 3vf3 | 85.16 | | 1370. |
107 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0go | Crystal Structure of Human Beta Secretase in Complex with NVP-AVI326 | 3veu | 84.44 | | 55. |
108 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0bi | Human BACE-1 complex with NB-216 | 3k5c | 83.77 | | 17. |
109 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 012 | Crystal structure of BACE-1 in complex with inhibitor | 3ckp | 81.5 | | 449. |
110 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 009 | Crystal structure of BACE-1 in complex with inhibitor | 3ckr | 77.52 | | 5001. |
111 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | cmz | X-ray crystal structure of beta secretase complexed with compound 5 | 2of0 | 73.76 | | no data |
112 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 9ip | X-ray crystal structure of beta secretase complexed with compound 6b | 2ohs | 76 | | 40000. |
113 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | xx4 | Structure of BACE complexed to compound 1 | 2q11 | 79.09 | | 900. |
114 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 251 | BACE1 with Compound 1 | 2qu2 | 75.09 | | 3700. |
115 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 462 | BACE1 with Compound 2 | 2qu3 | 79.42 | | 590. |
116 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c8c | X-ray crystal structure of beta secretase complexed with compound 8c | 2va5 | 72.49 | | 86000. |
117 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vg7 | Human BACE-1 in complex with N-((1S,2R)-3-(cyclohexylamino)-2-hydroxy- 1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl) benzamide | 2vj9 | 88.62 | | 180. |
118 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | f1h | Crystal structure of the human BACE1 catalytic domain in complex with N-(1-benzyl-piperidin-4-yl)-4-mercapto-butyramide | 2zjh | 74.83 | | no data |
119 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | f1i | Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(2,6-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide | 2zji | 75.76 | | no data |
120 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | f1k | Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid(3-mercapto-propyl)-amide | 2zjk | 75.57 | | no data |
121 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | f1l | Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-bromo-2,3-dimethoxy-benzyl)-piperidin-4-yl]-4-mercapto-butyramide | 2zjl | 82.77 | | no data |
122 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | aed | BACE-1 complexed with compound 4 | 3buh | 73.98 | | 220000. |
123 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | b35 | Discovery of aminoheterocycles as a novel beta-secretase inhibitor class | 3h0b | 86.37 | | 3200. |
124 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 454 | Bace-1 with Compound 3 | 3igb | 69.65 | | 38000. |
125 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 472 | Bace1 with Compound 30 | 3in3 | 78.87 | | 60. |
126 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bx2 | Bace1 with Compound 38 | 3in4 | 73.28 | | 30. |
127 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 593 | Bace1 with the aminohydantoin Compound 29 | 3ind | 77.23 | | 1530. |
128 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | x17 | Bace1 with the aminohydantoin Compound S-34 | 3ine | 75.54 | | 170. |
129 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | x45 | Bace1 with the aminohydantoin Compound 37 | 3inf | 76.27 | | 40. |
130 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 569 | Bace1 with the aminohydantoin Compound R-58 | 3inh | 80.14 | | 20. |
131 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | g00 | Structure of BACE bound to SCH346572 | 3kmx | 87.85 | | 15000. |
132 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | d8y | Structure of BACE bound to SCH12472 | 3kmy | 80.2 | | 32000. |
133 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bdj | Structure of BACE Bound to SCH710413 | 3l59 | 70.04 | | 200000. |
134 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bdo | Structure of BACE Bound to SCH713601 | 3l5b | 62.04 | | 123000. |
135 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bdq | Structure of BACE Bound to SCH723871 | 3l5c | 55.16 | | 7000. |
136 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bdv | Structure of BACE Bound to SCH723873 | 3l5d | 61.47 | | 78000. |
137 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bdx | Structure of BACE Bound to SCH736201 | 3l5f | 80.15 | | 605. |
138 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | z81 | Bace1 in complex with the aminohydantoin Compound 4g | 3lhg | 74.51 | | 20. |
139 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | ev4 | Fragment Based Discovery and Optimisation of BACE-1 Inhibitors | 3msk | 69.34 | | 26000. |
140 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 842 | SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors | 4i0j | 86.52 | | no data |
141 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 842 | BACE-1 in complex with ELN380842 | 3n4l | 86.35 | | 59. |
142 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | zoo | Bace1 in complex with the aminohydantoin Compound 102 | 3ooz | 83.19 | | 14. |
143 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | rtm | Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-cyclohexyl-N-methylpropanamide | 3rtm | 68 | | 38400. |
144 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3ru | Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-(cyclohexylmethyl)propanamide | 3ru1 | 81.3 | | 14200. |
145 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 591 | Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors | 3s7l | 78.53 | | 80. |
146 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 532 | Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors | 3s7m | 80.86 | | 10. |
147 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | b00 | Crystal Structure of beta secetase in complex with 2-amino-3-methyl-6-((1S, 2R)-2-phenylcyclopropyl)pyrimidin-4(3H)-one | 3vv6 | 74.25 | | 157000. |
148 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0b1 | Crystal Structure of beta secetase in complex with 2-amino-6-((1S,2R)-2-(3'-methoxybiphenyl-3-yl)cyclopropyl)-3-methylpyrimidin-4(3H)-one | 3vv7 | 76.31 | | 4600. |
149 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | b02 | Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1S,2R)-2-(3'-methylbiphenyl-4-yl)cyclopropyl)pyrimidin-4(3H)-one | 3vv8 | 78.31 | | 17100. |
150 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0b3 | Crystal Structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-tetrahydropyrimidin-4-one | 3wb4 | 72.29 | | 36600. |
151 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0b4 | Crystal Structure of beta secetase in complex with (6S)-2-amino-3,6-dimethyl-6-[(1R,2R)-2-phenylcyclopropyl]-3,4,5,6-tetrahydropyrimidin-4-one | 3wb5 | 74.9 | | 26800. |
152 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 6t9 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Ethoxy-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j0t | 80.95 | | 184. |
153 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | wzv | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND | 3zov | 80.83 | | 60. |
154 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 32d | Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatment of Alzheimer Disease | 4b05 | 86 | | 26.1 |
155 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 6t6 | New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain | 4b1e | 76.26 | | no data |
156 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | kgg | Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain | 4b78 | 78.03 | | 10000. |
157 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 8t3 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND | 4bfd | 85.27 | | 96. |
158 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0kk | Structure of BACE Bound to 2-imino-3-methyl-5,5-diphenylimidazolidin-4-one | 4dju | 73.77 | | 3600. |
159 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0kp | Structure of BACE Bound to 2-imino-3-methyl-5-phenyl-5-(3-(pyridin-3-yl)phenyl)imidazolidin-4-one | 4djw | 77.52 | | 530. |
160 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0kq | Structure of BACE Bound to 5-(3-(5-chloropyridin-3-yl)phenyl)-5-cyclopropyl-2-imino-3-methylimidazolidin-4-one | 4djx | 79.44 | | 59. |
161 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0mp | Structure of Bace-1 (Beta-Secretase) in complex with N-((2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-((6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)butan-2-yl)acetamide | 4dus | 85.08 | | 5. |
162 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 996 | Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors | 4ewo | 86.65 | | 44. |
163 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0up | Crystal Structure of BACE with Compound 14g | 4fm7 | 78.59 | | 57. |
164 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0uq | Crystal Structure of BACE with Compound 12a | 4fm8 | 79.3 | | 1060. |
165 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0va | crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with N-(N-(4-amino-3,5- dichlorobenzyl)carbamimidoyl)-3-(4-methoxyphenyl)-5- methyl-4-isothiazolecarboxamide | 4fse | 86.24 | | 40. |
166 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0vb | Crystal structure of beta-site app-cleaving enzyme 1 (BACE-DB-MUT) complex with N-(N-(4- acetamido-3-chloro-5-methylbenzyl)carbamimidoyl)-3-(4- methoxyphenyl)-5-methyl-4-isothiazolecarboxamide | 4fsl | 82.64 | | 20. |
167 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 10j | Structure of BACE-1 Bound to (7aR)-6-benzoyl-7a-(4-(3-cyanophenyl)thiophen-2-yl)-3-methyl-4-oxohexahydro-1H-pyrrolo[3,4-d]pyrimidin-2(3H)-iminium | 4h1e | 81.51 | | 3. |
168 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 10q | Structure of BACE Bound to 2-((7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-2-imino-3-methyl-4-oxohexahydro-1H-pyrrolo[3,4-d]pyrimidin-6(2H)-yl)nicotinonitrile | 4h3g | 83.41 | | 6. |
169 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 10v | Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(3-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-3-yl)benzonitrile | 4h3i | 72.12 | | 3. |
170 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 10w | Structure of BACE Bound to 2-fluoro-5-(5-(2-imino-3-methyl-4-oxo-6-phenyloctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-2-yl)benzonitrile | 4h3j | 86.38 | | 90. |
171 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0za | Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates | 4hzt | 85.17 | | 750. |
172 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1bf | Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | 4i0f | 83.43 | | 450. |
173 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1b9 | Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | 4i0g | 83.89 | | no data |
174 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1ch | Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates. | 4i11 | 74.19 | | 27200. |
175 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vsi | Crystal structure of BACE1 with its inhibitor | 4ivs | 70.5 | | 44. |
176 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | vti | Crystal structure of BACE1 with its inhibitor | 4ivt | 81.12 | | 1010. |
177 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1h7 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R)-2-amino-5-fluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j0v | 80.83 | | 28. |
178 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1h6 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5S)-2-amino-5-fluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j0y | 81.97 | | 435. |
179 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1h5 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,5R)-2-amino-5-fluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j0z | 80.68 | | 77. |
180 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1ho | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-5,5-difluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j1c | 80.88 | | 49. |
181 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1hm | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-4-fluoromethyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j1e | 78.62 | | 19. |
182 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1hl | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j1f | 79.05 | | 12. |
183 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1hj | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6R)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j1h | 76.51 | | 776. |
184 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1hh | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6R)-2-amino-5-fluoro-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j1i | 77.46 | | 40. |
185 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1hg | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6S)-2-amino-5-fluoro-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j1k | 77.14 | | 13. |
186 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1m7 | Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors | 4jpe | 76.63 | | 48. |
187 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1w1 | Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fused Bicyclic Aminooxazoline Compounds and Evaluation of Their Biochemical Activity Against Beta-Secretase-1 (BACE-1) | 4l7h | 81.32 | | 200000. |
188 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1w2 | Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fused Bicyclic Aminooxazoline Compounds and Evaluation of Their Biochemical Activity Against Beta-Secretase-1 (BACE-1) | 4l7j | 83.73 | | 200000. |
189 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1wp | Aminooxazoline inhibitor of BACE-1 | 4lc7 | 76.44 | | 11800. |
190 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 2ex | Discovery of 7-THP chromans: BACE1 inhibitors that reduce A-beta in the CNS | 4n00 | 76.75 | | 9.5 |
191 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3j9 | 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors | 4r5n | 77.33 | | 76. |
192 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3ko | BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((R)-1-(2-cyclopentylacetyl)pyrrolidin-3-yl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium | 4r8y | 79.96 | | 640. |
193 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3kt | BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(cyclopentylamino)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium | 4r91 | 81.45 | | 430. |
194 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3ku | BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(isonicotinamido)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium | 4r92 | 76.13 | | 39. |
195 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 779 | BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-1-methyl-5-oxo-4-(((1S,3R)-3-(3-phenylureido)cyclohexyl)methyl)imidazolidin-2-iminium | 4r93 | 73.35 | | 16. |
196 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3uw | 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors | 4rrn | 75.35 | | 48. |
197 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3ux | 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors | 4rro | 75.39 | | 26. |
198 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3uy | 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors | 4rrs | 76.01 | | 210. |
199 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3vo | Crystal structure of human BACE-1 bound to Compound 24B | 4wy1 | 79.08 | | 5100. |
200 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3vp | Crystal structure of human BACE-1 bound to Compound 36 | 4wy6 | 78.65 | | 1070. |
201 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3wp | Crystal structure of human BACE-1 bound to Compound 6 | 4x2l | 78.42 | | 36000. |
202 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | si5 | Crystal structure of BACE1 with a pyrazole-substituted tetrahydropyran thioamidine | 4xxs | 86.84 | | 52. |
203 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 5qv | Compound 18 | 5enk | 75.02 | | 8. |
204 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 5qu | Compound 10 | 5enm | 73.17 | | 70. |
205 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 60y | BACE-1 in complex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoropyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium | 5hd0 | 79.07 | | 4. |
206 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 60w | BACE-1 incomplex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoro-4-methoxypyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium | 5hdu | 89.85 | | 1. |
207 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 60v | BACE-1 incomplex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium | 5hdv | 73.65 | | 15. |
208 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 60u | BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(4-ethoxy-5-fluoro-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium | 5hdx | 75.94 | | 48. |
209 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 954 | BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylthio)pyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium | 5hdz | 78.57 | | 45. |
210 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 60t | BACE-1 in complex with (4aR,7aS)-7a-(2,6-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium | 5he4 | 81.63 | | 20. |
211 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 60s | BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylamino)pyrimidin-2-yl)-3-methyl-4-oxooctahydro-2H-pyrrolo[3,4-d]pyrimidin-2-iminium | 5he5 | 78.98 | | 336. |
212 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 60x | BACE-1 in complex with (4aR,7aS)-7a-(2,4-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyloctahydro-4H-pyrrolo[3,4-d]pyrimidin-4-one | 5he7 | 81.59 | | 5. |
213 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 6wd | (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amine (compound 12) bound to BACE1 | 5kqf | 70.05 | | 310. |
214 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 6we | (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine (compound 5) bound to BACE1 | 5kr8 | 72.75 | | 150. |
215 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | iii | BACE-1 IN COMPLEX WITH LIGAND 32397778 | 5mxd | 75.77 | | no data |
216 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 74b | Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality | 5t1w | 80.8 | | 77. |
217 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | p6u | Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality | 5t1u | 77.79 | | 69. |
218 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0b5 | Structure of BACE1 in complex with N-(3-((4R,5R,6S)-2-amino-6-(1,1-difluoroethyl)-5-fluoro-4-methyl-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide | 5ygx | 81.16 | | no data |
219 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | djs | BACE crystal structure with hydroxy pyrrolidine inhibitor | 6bfd | 89.73 | | 5. |
220 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | dk7 | BACE crystal structure with hydroxy morpholine inhibitor | 6bfw | 82.45 | | 220. |
221 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | ej7 | Structure of Bace-1 (Beta-Secretase) in complex with : N-(3-((1R,5S,6R)-3-amino-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-5-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide | 6c2i | 81.19 | | no data |
222 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | b7e | BACE1 compound 28 | 6ej2 | 83.16 | | no data |
223 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | b7t | BACE1 compound 23 | 6ej3 | 81.05 | | no data |
224 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | d9w | Crystal Structure of Human BACE-1 in Complex with amino-1,4-oxazine compound 4 | 6fgy | 82.63 | | no data |
225 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | dkj | BACE crystal structure with hydroxy pyrrolidine inhibitor | 6bfx | 83.07 | | 79. |
226 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | djv | BACE crystal structure with hydroxy pyrrolidine inhibitor | 6bfe | 91.43 | | 1400. |
227 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0b6 | Crystal Structure of BACE1 in complex with (S)-N-(3-(2-amino-6-(fluoromethyl)-4 -methyl-4H-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide | 5ygy | 77.21 | | no data |
228 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 7h3 | CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,6-TETRAHYDRO-7AH-FURO[2,3-D][1,3]THIAZIN-7A-YL)-4-FLUOROPHENYL)-5-BROMO-2-PYRIDINECARBOXAMIDE | 5tol | 81.67 | | 33. |
229 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 68l | Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene inhibitor 2 | 5i3w | 87.53 | | 0.6 |
230 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 66f | BACE1 in complex with (R)-N-(3-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropicolinamide | 5hu1 | 87.43 | | 2.2 |
231 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 66h | BACE1 in complex with 4-(3-(furan-2-carboxamido)phenyl)-1-methyl-5-oxo-4-phenylimidazolidin-2-iminium | 5hu0 | 80.83 | | 595. |
232 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 5t7 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (1SR,2SR)-2-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-1,3-oxazin-4-yl)-N-(3-chloroquinolin-8-yl)cyclopropanecarboxamide | 5f01 | 79.41 | | 420. |
233 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 5t8 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-[3-[(3-chloro-8-quinolyl)amino]phenyl]-5-methyl-2,6-dihydro-1,4-oxazin-3-amine | 5f00 | 79.57 | | 250. |
234 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 52k | 1,4-Oxazine BACE1 inhibitors | 5clm | 81.71 | | 44. |
235 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 4ry | BACE crystal structure with tricyclic aminothiazine inhibitor | 4zsr | 79.17 | | 36100. |
236 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 4rx | BACE crystal structure with tricyclic aminothiazine inhibitor | 4zsq | 81.01 | | 2250. |
237 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 4rz | BACE crystal structure with bicyclic aminothiazine inhibitor | 4zsp | 79.5 | | 1830. |
238 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3ys | Crystal Structure of BACE with amino thiazine inhibitor LY2886721 | 4x7i | 83.89 | | 20.3 |
239 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1hq | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-difluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j17 | 81.98 | | 54. |
240 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1h8 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4j0p | 81.08 | | 51. |
241 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1bs | Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates | 4i10 | 80.15 | | 170. |
242 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1bb | Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates | 4i0z | 76.64 | | 470. |
243 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 10o | Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(6-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-3-yl)benzonitrile | 4h3f | 83.74 | | 1. |
244 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 0kr | Structure of BACE Bound to (R)-5-cyclopropyl-2-imino-3-methyl-5-(3-(5-(prop-1-yn-1-yl)pyridin-3-yl)phenyl)imidazolidin-4-one | 4djy | 79.38 | | 5.4 |
245 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 1b1 | New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain | 4b1c | 84.89 | | 79. |
246 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | gmf | Lead Generation of BACE1 Inhibitors by Coupling Non-amidine New Warheads to a Known Binding Scaffold | 4b0q | 85.67 | | no data |
247 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | s8z | Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 23 | 4acx | 89.33 | | 77.6 |
248 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | qn7 | Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 14 | 4acu | 84.92 | | 40.7 |
249 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 09e | Crystal Structure of BACE with Compound 13 | 3udq | 83.8 | | 1000. |
250 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 09d | Crystal Structure of BACE with Compound 12 | 3udp | 85.4 | | 6000. |
251 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 18p | Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors | 3u6a | 79.83 | | 324. |
252 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | ev6 | Fragment based discovery and optimisation of bace-1 inhibitors | 3s2o | 71.54 | | 8900. |
253 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3p5 | Crystal Structure of Human Beta Secretase in Complex with BFG356 | 3pi5 | 86.54 | | 950. |
254 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | ev5 | Fragment Based Discovery and Optimisation of BACE-1 Inhibitors | 3msl | 68.83 | | 7000. |
255 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 3to | Structure of BACE bound to SCH708236 | 3kn0 | 77.3 | | 250000. |
256 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | bav | Crystal structure of human beta-secretase in complex with NVP-BAV544 | 3dv5 | 86.16 | | 22. |
257 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | f1j | Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid (2-mercapto-ethyl)-amide | 2zjj | 92.4 | | no data |
258 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 310 | X-ray structure of Bace-1 in complex with compound 3.b.10 | 2zdz | 80.59 | | 700. |
259 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | c27 | X-ray crystal structure of beta secretase complexed with compound 27 | 2va7 | 78.71 | | 200. |
260 | BACE1 | Beta-secretase 1 | P56817 | BACE KIAA1149 | 8ip | X-ray crystal structure of beta secretase complexed with compound 6a | 2ohr | 72.92 | | 100000. |
261 | BACE2 | Beta-secretase 2 | Q9Y5Z0 | AEPLC ALP56 ASP21 | c7o | BACE2 xaperone complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide | 6jsz | 72.77 | | no data |
262 | BACE2 | Beta-secretase 2 | Q9Y5Z0 | AEPLC ALP56 ASP21 | wzv | BACE2 XAPERONE COMPLEX WITH INHIBITOR | 3zks | 78.5 | | no data |
263 | BACE2 | Beta-secretase 2 | Q9Y5Z0 | AEPLC ALP56 ASP21 | wzv | BACE2 FAB INHIBITOR COMPLEX | 3zkn | 65.08 | | no data |
264 | BACE2 | Beta-secretase 2 | Q9Y5Z0 | AEPLC ALP56 ASP21 | wzv | BACE2 MUTANT STRUCTURE WITH LIGAND | 3zki | 78.57 | | 1200. |
265 | BACE2 | Beta-secretase 2 | Q9Y5Z0 | AEPLC ALP56 ASP21 | 6t9 | BACE2 XAPERONE COMPLEX | 3zlq | 79.81 | | 904. |
266 | RENI | Renin | P00797 | | s53 | Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors | 3sfc | 91.78 | | 3. |
267 | RENI | Renin | P00797 | | rx6 | Clinically Useful Alkyl Amine Renin Inhibitors | 3q5h | 89.96 | | 560. |
268 | RENI | Renin | P00797 | | rx5 | Clinically Useful Alkyl Amine Renin Inhibitors | 3q4b | 89.13 | | 0.47 |
269 | RENI | Renin | P00797 | | rpf | crystal structure of renin-pf00257567 complex | 2bkt | 88.12 | | 23. |
270 | RENI | Renin | P00797 | | r32 | Human renin in complex with compound 18 | 3vsx | 85.46 | | 1.4 |
271 | RENI | Renin | P00797 | | hhe | Human renin in complex with compound 5 | 3vuc | 83.07 | | 0.9 |
272 | RENI | Renin | P00797 | | c41 | Crystal Structure of Renin with Inhibitor 10 (Aliskiren) | 2v0z | 88.9 | | 0.6 |
273 | RENI | Renin | P00797 | | bfx | New Classes of Potent and Bioavailable Human Renin Inhibitors | 3k1w | 88.06 | | no data |
274 | RENI | Renin | P00797 | | 9g7 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | 5vpm | 86.38 | | 1.6 |
275 | RENI | Renin | P00797 | | 90d | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | 5v8v | 80 | | 1.3 |
276 | RENI | Renin | P00797 | | 7ek | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | 5tmg | 95.09 | | no data |
277 | RENI | Renin | P00797 | | 7ej | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | 5tmk | 87.96 | | no data |
278 | RENI | Renin | P00797 | | 72x | Crystal structure of human renin complexed with a novel inhibitor | 3gw5 | 89.09 | | 0.47 |
279 | RENI | Renin | P00797 | | 6vs | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | 5kos | 90.72 | | 1.5 |
280 | RENI | Renin | P00797 | | 6ig | Ketopiperazine-Based Renin Inhibitors: Optimization of the ""C"" Ring | 2g22 | 89.86 | | no data |
281 | RENI | Renin | P00797 | | 4lg | Ketopiperazine-Based Renin Inhibitors: Optimization of the ""C"" Ring | 2g27 | 88.33 | | no data |
282 | RENI | Renin | P00797 | | 3zn | RENIN IN COMPLEXED WITH (3S,4S)-4-({[4-methoxy-3-(3-methoxypropoxy)benzoyl](propan-2-yl)amino}methyl)pyrrolidin-3-yl benzylcarbamate INHIBITOR | 4rz1 | 87.71 | | 40. |
283 | RENI | Renin | P00797 | | 3zk | RENIN IN COMPLEXED WITH 4-methoxy-3-(3-methoxypropoxy)-N-{[(3S,4S)-4-{[(4-methylphenyl)sulfonyl]amino}pyrrolidin-3-yl]methyl}-N-(propan-2-yl)benzamide INHIBITOR | 4ryc | 89.18 | | 80. |
284 | RENI | Renin | P00797 | | 3zj | RENIN IN COMPLEXED WITH N-({(3S,4S)-4-[(benzylsulfonyl)amino]pyrrolidin-3-yl}methyl)-4-methoxy-3-(3-methoxypropoxy)-N-(propan-2-yl)benzamide INHIBITOR | 4ryg | 89.76 | | 8. |
285 | RENI | Renin | P00797 | | 22x | Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors | 3km4 | 95.81 | | 1.3 |
286 | RENI | Renin | P00797 | | 0qb | CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS | 1bim | 83.54 | | 1.2 |
287 | RENI | Renin | P00797 | | 0n0 | Crystal structure of renin in complex with NVP-BGQ311 (compound 12) | 4gjd | 86.26 | | 3. |
288 | RENI | Renin | P00797 | | 0lu | Crystal structure of renin in complex with PKF909-724 (compound 3) | 4gj8 | 92.91 | | 500000. |
289 | RENI | Renin | P00797 | | 0iu | CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS | 1bil | 85.2 | | 0.5 |
290 | RENI | Renin | P00797 | | 03d | HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS | 1hrn | 88.83 | | 9. |
291 | RENI | Renin | P00797 | | 1ig | Ketopiperazine-based renin inhibitors: Optimization of the ""C"" ring | 2g1n | 89.33 | | no data |
292 | RENI | Renin | P00797 | | 5ig | Ketopiperazine-Based Renin Inhibitors: Optimization of the ""C"" Ring | 2g1y | 90.29 | | 90. |
293 | RENI | Renin | P00797 | | 7ig | Crystal Structure of Human Renin Complexed with Inhibitor | 2iko | 77.77 | | 3571. |
294 | RENI | Renin | P00797 | | 7ig | Ketopiperazine-Based Renin Inhibitors: Optimization of the ""C"" Ring | 2g24 | 78 | | 4000. |
295 | RENI | Renin | P00797 | | c40 | Crystal Structure of Renin with Inhibitor 7 | 2v13 | 89.76 | | 26. |
296 | RENI | Renin | P00797 | | c47 | Crystal Structure of Renin with Inhibitor 3 | 2v16 | 86.81 | | 6. |
297 | RENI | Renin | P00797 | | ssr | Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes | 3oot | 90.11 | | 2. |
298 | RENI | Renin | P00797 | | s51 | Crystal Structure Analysis of Renin-indole-piperazine inhibitor complexes | 3oqf | 88.84 | | 91. |
299 | RENI | Renin | P00797 | | s52 | Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes | 3oqk | 89.67 | | 420. |
300 | RENI | Renin | P00797 | | rx0 | Alkyl Amine Renin Inhibitors: Filling S1 from S3 | 3q3t | 88.52 | | 37. |
301 | RENI | Renin | P00797 | | vyd | Human renin in complex with inhibitor 6 | 3vyd | 82.27 | | 406. |
302 | RENI | Renin | P00797 | | vye | Human renin in complex with inhibitor 7 | 3vye | 81.85 | | 7.7 |
303 | RENI | Renin | P00797 | | vyf | Human renin in complex with inhibitor 9 | 3vyf | 85.89 | | 1.6 |
304 | RENI | Renin | P00797 | | 0lt | Crystal structure of renin in complex with NVP-BCA079 (compound 12a) | 4gj7 | 91.48 | | 170. |
305 | RENI | Renin | P00797 | | 0m3 | Crystal structure of renin in complex with NVP-AYL747 (compound 5) | 4gja | 85.24 | | 1200. |
306 | RENI | Renin | P00797 | | 0me | Crystal structure of renin in complex with NVP-BBV031 (compound 6) | 4gjb | 84.54 | | 100000. |
307 | RENI | Renin | P00797 | | 0mj | Crystal structure of renin in complex with NVP-BCH965 (compound 9) | 4gjc | 85.02 | | 90. |
308 | RENI | Renin | P00797 | | 2xf | Crystal structure of renin in complex with compound4 | 4pyv | 82.02 | | 200. |
309 | RENI | Renin | P00797 | | 2y9 | Structure-based design of 4-hydroxy-3,5-substituted piperidines as direct renin inhibitors | 4q1n | 86.73 | | 0.2 |
310 | RENI | Renin | P00797 | | 43t | Renin in complex with (S)-1-(3-fluoro-5-(((S)-1-phenylethyl)carbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium | 4s1g | 88.02 | | 0.6 |
311 | RENI | Renin | P00797 | | 70x | Renin in complex with (S)-1-(3-(benzylcarbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium | 4xx3 | 88.62 | | 56. |
312 | RENI | Renin | P00797 | | 6vr | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | 5koq | 90.29 | | 0.58 |
313 | RENI | Renin | P00797 | | 6vu | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | 5kot | 94.95 | | no data |
314 | RENI | Renin | P00797 | | 74y | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | 5sz9 | 89.13 | | 38000. |
315 | RENI | Renin | P00797 | | 74z | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | 5sy3 | 97.95 | | 43000. |
316 | RENI | Renin | P00797 | | 74v | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | 5sy2 | 91.42 | | 11000. |
317 | RENI | Renin | P00797 | | 74u | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | 5sxn | 91.89 | | 11000. |
318 | RENI | Renin | P00797 | | 70y | Renin in complex with (4S)-4-isopropyl-4-methyl-6-oxo-1-(3-(2-oxo-4-phenylpyrrolidin-1-yl)benzyl)tetrahydropyrimidin-2(1H)-iminium | 4xx4 | 86.75 | | 44. |
319 | RENI | Renin | P00797 | | 0m2 | Crystal structure of renin in complex with GP055321 (compound 4) | 4gj9 | 92.62 | | 500000. |
320 | RENI | Renin | P00797 | | liy | Crystal Structure of Human Renin Complexed with Inhibitors | 2iku | 85.83 | | 79. |
321 | RENI | Renin | P00797 | | ua4 | Human renin/PF02342674 complex | 2i4q | 83.09 | | no data |
322 | RENI | Renin | P00797 | | l1b | Ketopiperazine-Based Renin Inhibitors: Optimization of the ""C"" Ring | 2g21 | 91.44 | | no data |
323 | RENI | Renin | P00797 | | 4ig | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | 2g1s | 83.43 | | no data |
324 | RENI | Renin | P00797 | | 3ig | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | 2g1r | 89.41 | | 20. |
325 | RENI | Renin | P00797 | | 2ig | Ketopiperazine-Based Renin Inhibitors: Optimization of the ""C"" Ring | 2g1o | 90.56 | | no data |